Page 251 - Binder2

support from global health organizations and regulatory
innovators.

The implications are profound:

• Shorter supply chains
• Lower environmental footprint
• Reduced reliance on pharma conglomerates
• Empowered regional biotech ecosystems

This is what it means to decentralize health innovation.

A New Model for Equity

Edible biologics enable a new kind of equity—not just
access to a drug, but access to production.

Unlike traditional biologics, which require multi-million-
dollar facilities and specialized personnel, edible platforms
can be:

• Grown in contained hydroponic systems
• Processed with minimal downstream equipment
• Packaged in ambient-stable formats
• Deployed by local health workers with minimal
training

This opens up new avenues for:

• Humanitarian deployment in conflict or disaster
zones
• Disease prevention in rural or low-infrastructure
settings

249